Jeet Mukherjee
Stock Analyst at BTIG
(4.05)
# 1,804
Out of 5,081 analysts
161
Total ratings
46.3%
Success rate
9.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Reiterated: Buy | $29 | $15.36 | +88.80% | 6 | Oct 26, 2026 | |
| BCAX Bicara Therapeutics | Reiterated: Buy | $39 | $16.89 | +130.91% | 9 | Oct 26, 2026 | |
| FTH Faeth Therapeutics | Reiterated: Buy | $55 | $16.83 | +226.80% | 7 | Oct 26, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $14 | $1.21 | +1,057.02% | 11 | Oct 25, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $26 | $8.96 | +190.34% | 3 | Oct 25, 2026 | |
| VSTM Verastem | Reiterated: Buy | $24 | $10.00 | +140.00% | 9 | Oct 19, 2026 | |
| IBRX ImmunityBio | Reiterated: Buy | $12 | $7.81 | +53.65% | 8 | Oct 14, 2026 | |
| PVLA Palvella Therapeutics | Reiterated: Buy | $215 | $126.23 | +70.32% | 11 | Oct 12, 2026 | |
| QNRX Quoin Pharmaceuticals | Initiated Coverage: Buy | $14 | $4.01 | +249.13% | 1 | Oct 12, 2026 | |
| FHTX Foghorn Therapeutics | Downgraded: Hold | n/a | $2.05 | - | 6 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $24.21 | +416.32% | 6 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.46 | +516.44% | 7 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $15.45 | +210.68% | 5 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.08 | - | 10 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 → $133 | $70.54 | +88.55% | 17 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 | $25.55 | +25.24% | 12 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 → $134 | $114.84 | +16.68% | 13 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $7.31 | +146.24% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.62 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $20.39 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.1897 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $41.49 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $16.69 | n/a | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $32.88 | n/a | 1 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0003 | n/a | 1 | Apr 1, 2025 |
ArriVent BioPharma
Oct 26, 2026
Reiterated: Buy
Price Target: $29
Current: $15.36
Upside: +88.80%
Bicara Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $39
Current: $16.89
Upside: +130.91%
Faeth Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $55
Current: $16.83
Upside: +226.80%
Perspective Therapeutics
Oct 25, 2026
Reiterated: Buy
Price Target: $14
Current: $1.21
Upside: +1,057.02%
ORIC Pharmaceuticals
Oct 25, 2026
Reiterated: Buy
Price Target: $26
Current: $8.96
Upside: +190.34%
Verastem
Oct 19, 2026
Reiterated: Buy
Price Target: $24
Current: $10.00
Upside: +140.00%
ImmunityBio
Oct 14, 2026
Reiterated: Buy
Price Target: $12
Current: $7.81
Upside: +53.65%
Palvella Therapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: $215
Current: $126.23
Upside: +70.32%
Quoin Pharmaceuticals
Oct 12, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $4.01
Upside: +249.13%
Foghorn Therapeutics
Oct 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $2.05
Upside: -
Sep 22, 2026
Reiterated: Buy
Price Target: $125
Current: $24.21
Upside: +416.32%
Sep 17, 2026
Reiterated: Buy
Price Target: $9
Current: $1.46
Upside: +516.44%
Aug 20, 2026
Reiterated: Buy
Price Target: $48
Current: $15.45
Upside: +210.68%
Aug 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.08
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: $117 → $133
Current: $70.54
Upside: +88.55%
Jul 1, 2026
Rated: Buy
Price Target: $32
Current: $25.55
Upside: +25.24%
Jun 25, 2026
Reiterated: Buy
Price Target: $138 → $134
Current: $114.84
Upside: +16.68%
May 13, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $7.31
Upside: +146.24%
May 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.62
Upside: n/a
May 23, 2025
Reiterated: Buy
Price Target: $91
Current: $20.39
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: $12
Current: $0.1897
Upside: n/a
May 13, 2025
Initiated Coverage: Buy
Price Target: $42
Current: $41.49
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $100
Current: $16.69
Upside: n/a
Apr 14, 2025
Reiterated: Buy
Price Target: $62
Current: $32.88
Upside: n/a
Apr 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0003
Upside: n/a